Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Cash from Financing Activities: 2019-2024

Historic Cash from Financing Activities for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Dec 2024 value amounting to -$235.7 million.

  • Maravai Lifesciences Holdings' Cash from Financing Activities fell 1119.65% to -$8.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$250.9 million, marking a year-over-year decrease of 26591.24%. This contributed to the annual value of -$235.7 million for FY2024, which is 285.84% down from last year.
  • Maravai Lifesciences Holdings' Cash from Financing Activities amounted to -$235.7 million in FY2024, which was down 285.84% from -$61.1 million recorded in FY2023.
  • Maravai Lifesciences Holdings' 5-year Cash from Financing Activities high stood at $53.2 million for FY2020, and its period low was -$235.7 million during FY2024.
  • Over the past 3 years, Maravai Lifesciences Holdings' median Cash from Financing Activities value was -$187.5 million (recorded in 2022), while the average stood at -$161.4 million.
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Cash from Financing Activities skyrocketed by 1,376.99% in 2020, and later tumbled by 398.90% in 2021.
  • Over the past 5 years, Maravai Lifesciences Holdings' Cash from Financing Activities (Yearly) stood at $53.2 million in 2020, then tumbled by 398.90% to -$159.0 million in 2021, then dropped by 17.89% to -$187.5 million in 2022, then spiked by 67.42% to -$61.1 million in 2023, then slumped by 285.84% to -$235.7 million in 2024.